Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
 
Sponsors and Collaborators

Sidney Kimmel Comprehensive Cancer Center
The John P. Hussman Foundation
 
Contact
Susan Sartorius, RN
410-614-3644
 
Principal Investigators
William Sharfman, M.D.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
 
ClinicalTrials.gov Identifier
NCT01435499